-
Mashup Score: 0
At the 2022 NY GU Cancers Symposium, Jean Hoffman-Censits, MD, discussed the latest developments in the neoadjuvant and adjuvant setting for patients with bladder cancer.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
Dr. Jean Hoffman-Censits highlights the latest immunotherapy advances in the neoadjuvant and adjuvant settings in bladder cancer https://t.co/R9SBTueRBV #urology #urologist #bladder #bladdercancer #urothelialcarcincoma